国内埋藏式心脏转复除颤器临床应用面临的问题
被引量:4
摘要
国内埋藏式心脏转复除颤器(ICD)临床应用率很低。存在的问题主要包括医生对ICD适应证不知晓、过分相信其他疗法在预防心脏性猝死中的作用、患者对心脏性猝死缺乏了解,医疗保险报销比例太低、如何筛选高危患者和ICD的使用寿命和更换问题等。并对相应的问题提出了诸如扩大适应证宣传等解决策略。
出处
《中国心脏起搏与心电生理杂志》
2012年第5期377-380,共4页
Chinese Journal of Cardiac Pacing and Electrophysiology
参考文献12
-
1Hua W, Zhang LF, Wu YF, et al. Incidence of sudden cardiac death in China: analysis of 4 regional populations [ J ]. J Am Coil Cardiol, 2009,54(12) :1 110.
-
2Epstein AE, Kay GN, Plumb V J, et al. Implantable cardioverter-defibrillator prescription in the elderly [ J ]. Heart Rhythm, 2009,6 (8) :1 136.
-
3宿燕岗,吴妍,柏瑾,王蔚,葛均波.植入型心律转复除颤器适应证患者及主管医生的问卷调查[J].中华心律失常学杂志,2010,14(1):59-62. 被引量:10
-
4Bunch TJ, May HT, Bair TL, et al. Trends in early and late mortality in patients undergoing coronary catheterization for myocardial infarction: implications on observation periods and risk factors to de- termine ICD candidacy [ J ]. Heart Rhythm, 2011,8 (9) : 1 460.
-
5AI-Khatib SM, Hellkamp AS, Lee KL, et al. Implantable cardioverter defibrillator therapy in patients with prior coronary revascular- ization in the Sudden Cardiac Death in Heart Failure Trial ( SCD- Hell'F) [ J ]. J Cardiovasc Electrophysiol, 2008,19 (10) : 1 059.
-
6Sudzinova A, Stancak B, Sedlak J, et al. The effect of myocardial revascularization on malignant ventricular arrhythmias in coronary artery disease [ J ]. Bratisl Lek Listy,2009,110 (4) : 226.
-
7Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [ J ]. N Engl J Med, 2005,352 ( 3 ) : 225.
-
8Zipes DP, Carom AJ, Borggrefe M, et al. ACC/AHA/ESC 2006Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death : a report of the Ameri- can College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) : developed in collaboration with the Euro- pean Heart Rhythm Association and the Heart Rhythm Society[ J]. Circulation,2006,14 (10) : e385.
-
9van Welsenes GH, van Rees JB, Borleffs C J, et al. Long-term follow-up of primary and secondary prevention implantable eardioverter defibrillator patients [ J ]. Europace ,2011,13 ( 3 ) : 389.
-
10Wathen MS, DeGroot PJ, Sweeney MO, et al. Prospective randomized mnlticenter trial of empirical antitachycardia pacing remus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter defibrillators: PainFREE RxlI Trial Results [J]. Circulation, 2004,110:2 591.
二级参考文献9
-
1Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation ,2002,106:2145-2161.
-
2Swedberg K, Cleland J, Dargie H, et al. Guidelines for the Diagnosis and Treatment of Chronic Heart Failure: executive summary (update 2005 ) :The task force for the diagnosis and treatment of chronic heart failure of the european society of cardiology. Eur Heart J ,2005,26 : 1115-1140.
-
3Connolly S J, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study(CIDS) :A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation, 2000, 101 : 1297-1301.
-
4The Antiarrhythmics Verus Implantable Defibrillaton (AVID)Investigators. A comparison of Antiarrhythmic2drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med, 1997,337:1576-1583.
-
5Kuck KH, Cappao R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resudcitated from cardiac arrest. The cardiac arrest study Hamburg ( CASH ). Circulation, 2000,102 : 748 -753.
-
6Bardy GH, Lee KL, Mark DB, et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med ,2005,352:225-237.
-
7Feldman AM, de Lissovoy G, Bristow MR, et al. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure( COMPANION ) trial. J Am Coil Cardiol,2005 ,46 :2311-2321.
-
8ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary. J Am Coil Cardiol, 2008,51 : 2085 -2105,.
-
9Brown DW, Croft JB, Greenlund KJ, et al. Trends in hospitalization for the implantation of cardioverter-defibrillators in the Uniled States, 1990-2005. Am J Cardiol,2008,101 : 1753-1755.
共引文献9
-
1梁义秀,宿燕岗,柏瑾,王蔚,秦胜梅,汪菁峰,潘文志,葛均波.心脏性猝死一级与二级预防植入型心律转复除颤器患者临床特征单中心分析[J].中华心律失常学杂志,2012,16(3):180-183. 被引量:6
-
2姜文兵,孙雅逊,王毅,张建华,黄翯,蒋晨阳,傅国胜.老年人埋藏式心律转复除颤器误放电原因分析及处理[J].中华老年医学杂志,2013,32(5):465-468.
-
3植入型心律转复除颤器治疗的中国专家共识[J].中华心律失常学杂志,2014,18(4):242-253. 被引量:25
-
4朱雯晴,柏瑾,王蔚,吴妍,宿燕岗,葛均波.单中心植入型心律转复除颤器植入适应证患者5年随访[J].中华心律失常学杂志,2015,19(1):25-28. 被引量:2
-
5宿燕岗,梁义秀.慢性心衰心脏性猝死的一级预防及其策略[J].南京医科大学学报(自然科学版),2016,36(4):402-405. 被引量:6
-
6李冬九,李京波.心肌梗死后心脏性猝死危险分层存在的问题及研究进展[J].医学综述,2017,23(21):4276-4280.
-
7曾治宇,林娜,张明东,张澍.植入型心律转复除颤器一级预防的卫生经济学研究进展[J].心血管病学进展,2018,39(3):320-323. 被引量:1
-
8戴研,陈柯萍,于海波,李若谷,许静,赵玲,范洁,李莉.植入型心律转复除颤器二级预防适应证患者的问卷调查[J].中华心律失常学杂志,2020,24(5):458-462.
-
9梁义秀,汪菁峰,陈学颖,张磊,李明辉,潘磊,严冬,祁文玥,宿燕岗,葛均波.全皮下植入型心律转复除颤器应用与认知的问卷调查[J].中华心律失常学杂志,2022,26(5):428-432.
同被引文献33
-
1Uther J F. The automatic implantable defibrillator is the most realistic and cost-effective way of preeenting sudden cardiac [J]. Aust N Z J Med, 1992, 22(5 Suppl) : 636-638.
-
2Hua W, Zhang L F, Wu Y F, et al. Incidence of sudden cardiac death in China : Analysis of 4 regional populations [J]. J Am Coil Cardiol, 2009,54(12) : 1110 -1118.
-
3Muhicenter Post Infarction Research Group. Risk stratification and survival after myocardial infarction [J]. N Engl J Med, 1983,309(5) :331-336.
-
4Solomon S D, Zelenkofske S, MeMurray J J, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both [J]. N Engl J Med, 2005,352 (25) : 2581-2588.
-
5Daubert J P, Zareba W, Cannom D S, et al. Inappropriate implantable cardioverter-defibriilator shocks in MADIT-II : frequency, mechanisms, predictors, and survival impact [J]. J Am Coil Cardiol, 2008,51(14) : 1357- 1365.
-
6Van der Heijden AC, Borleffs CJ, Buiten MS, et al. The clini- cal course of patients with implantable cardioverter-defibrilla- tots: extended experience on clinical outcome, device replace- ments, and device-related complications[J]. Heart Rhythm, 2015, 12(6):1 169.
-
7Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopa- thy[J]. NEnglJ Med, 2004, 350(21):2 151.
-
8Daubert JP, Zareba W, Cannom DS, et al. Inappropriate im- plantable eardioverter-defibrillator shocks in MADIT II.. fre- quency, mechanisms, predictors, and survival impact [J]. J Am Coll Cardiol, 2008, 51(14):1 357.
-
9Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic im- portance of defibrillator shocks in patients with heart failure [J]. NEnglJ Med, 2008, 359(10):1 009.
-
10Kolb C, Sturmer M, Sick P,et al. Reduced risk for inappropri- ate implantable cardioverter-defibrillator shocks with dual- chamber therapy compared with single-chamber therapy: re- suits of the randomized OPTION study[J]. JACC Heart Fail, 2014,2(6) :611.
引证文献4
-
1付荣,姜东炬,薛博文,胡高频,贾玉琳,张燕波,王冬冬,陶爱萍.埋藏式心脏转复除颤器用于猝死一级预防临床应用8例[J].实用医学杂志,2013,29(23):3956-3957. 被引量:1
-
2蔡彬妮,黄卫斌,孟凡琦,周法光,郭晋村,王焱.埋藏式心脏转复除颤器的临床应用单中心经验[J].中国心脏起搏与心电生理杂志,2016,30(3):220-223. 被引量:1
-
3张紫莹,曾美玲,孙爱萍,王斐,丁雯.植入式心脏转复除颤术病人共同决策体验质性研究的Meta整合[J].循证护理,2023,9(13):2281-2287.
-
4史润泽,郝云霞,范秀云,张淑艳,李峥,康晓凤.基于Ottawa决策支持框架的植入型心律转复除颤器患者决策辅助工具编制[J].护理学报,2019,26(5):35-40. 被引量:11
二级引证文献13
-
1黄雪汝,王瑜.急性心梗介入手术中反复室颤的发生与酒石酸美托洛尔干预护理[J].实用医学杂志,2014,30(22):3665-3668. 被引量:8
-
2李金苒,汪芳.埋藏式心脏转复除颤器相关电风暴的发生机制[J].中国心脏起搏与心电生理杂志,2017,31(2):173-176. 被引量:1
-
3陶维玲.信息化营养辅助支持决策在神经外科护理的应用[J].护理学报,2019,26(21):67-70. 被引量:6
-
4张美红,高钰琳.基于渥太华决策支持框架的双J管留置患者自我管理健康教育视频内容构建[J].护士进修杂志,2020,35(8):682-686. 被引量:15
-
5张阔亮,郑苗,卞薇,张宝石,王丽华.我国医患共同决策的SWOT分析[J].现代医院管理,2020,18(4):20-23. 被引量:5
-
6陈园园,杨潇潇,孟繁洁.决策辅助在痴呆护理中的应用进展[J].护理学杂志,2021,36(2):109-112. 被引量:4
-
7张学梅,姜丽娟,虞亚蔚.急性缺血性卒中患者及家属参与静脉溶栓决策的质性研究[J].南通大学学报(医学版),2021,41(5):463-466. 被引量:3
-
8成忠莎,柏晓玲,谢贵华,张永春,易一乐,韦清,杨曾桢.人工心脏瓣膜置换患者决策辅助内容的构建[J].护理学报,2021,28(24):22-26. 被引量:5
-
9董芳香,陈茜,关艳娜,陈翠香,王丹,孙冬梅.共同决策在产科护理中的应用思考[J].中国实用护理杂志,2022,38(6):476-480. 被引量:2
-
10张静,张海鸽,程苗苗,高娜娜.量化评估策略下的保护性动机干预对心律失常经射频消融术患者认知水平的影响[J].中国医药导报,2023,20(5):180-184.
-
1柳青,翟伟.针灸治疗椎动脉型颈椎病的临床文献研究概况[J].中医临床研究,2013,5(21):114-116. 被引量:1
-
2谢川,吕农华.我国Hp感染诊疗中存在的问题与对策[J].医学新知,2013,23(6):419-420. 被引量:1
-
3中华医学会心电生理和起搏分会,中国生物医学工程学会心脏起搏与电生理分会ICD专家工作组.埋藏式心脏复律除颤器(ICD):目前认识和建议[J].中国心脏起搏与心电生理杂志,2002,16(5):321-325. 被引量:17
-
4张薇薇,郭子宽,李占全.间充质干细胞临床试验中的问题及其解决策略[J].中国实验血液学杂志,2007,15(4):901-904. 被引量:17
-
5于增艳,刘爱书,张修竹.儿童期社交退缩与人际关系的研究综述[J].中国健康心理学杂志,2006,14(3):358-360. 被引量:6
-
6刘佰明.大学外语学习中学生焦虑情绪的研究[J].齐齐哈尔医学院学报,2009,30(16):2047-2048.
-
7荣誉越高 压力越大[J].中国社区医师,2013(11):12-13.
-
8FDA批准抗HIV-1药物Isentress扩大适应证[J].齐鲁药事,2012,31(7):389-389.
-
9各地动态[J].山东卫生,2007(5):37-38.
-
10林文瑞,王壬.农民工子女社交问题解决策略的特点研究[J].中国健康心理学杂志,2009,17(12):1447-1449. 被引量:2